UPDATE: Morgan Stanley Starts Sophia Genetics SA (SOPH) at Overweight

Morgan Stanley analyst Tejas Savant initiates coverage on Sophia Genetics SA (NASDAQ: SOPH) with a Overweight rating and a price target of $24.00.

The analyst comments "Riding on the coattails of healthcare digitization, SOPH’s differentiated informatics platform is easy to deploy, affordable to access and capable of adding new data modalities over time, enabling precision medicine at scale; with a $35B TAM and penetration in the early innings, we initiate at OW."

For an analyst ratings summary and ratings history on Sophia Genetics SA click here. For more ratings news on Sophia Genetics SA click here.

Shares of Sophia Genetics SA closed at $18.09 yesterday.

You May Also Be Interested In

• B.Riley Starts Weave Communications Inc (WEAV) at Buy
• Marvell (MRVL) PT Raised to $225 at TD Cowen
• Chardan Downgrades EyePoint Inc. (EYPT) to Neutral